<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
	<title>CRB Discovery News Archive</title>
	<link>http://www.crbdiscovery.com/news/</link>
	<description>Latest announcements &amp; happenings from CRB</description>
	<language>en-gb</language>
	<copyright>Copyright 2012, Cambridge Research Biochemicals</copyright>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<item>
		<title><![CDATA[RCUK Shared Services Centre Ltd extends contract with Cambridge Research Biochemicals]]></title>
		<link>http://www.crbdiscovery.com/news/23_11-May-12.php</link>
		<description><![CDATA[<strong>Cleveland, UK:</strong> Leading research peptide manufacturer, <a href="http://www.crbdiscovery.com/home/">Cambridge Research Biochemicals (CRB)</a> announced today that it has extended its contract with RCUK Shared Services Centre Ltd (RCUK SSC Ltd) to supply custom synthesised peptides and custom generated polyclonal and monoclonal antibodies for a further 12 months.]]></description>
		<pubDate>Fri, 11 May 2012 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[Cambridge Research Biochemicals Signs Exclusive Japanese Distribution Deal with BioBridge]]></title>
		<link>http://www.crbdiscovery.com/news/22_27-Mar-12.php</link>
		<description><![CDATA[Cleveland, UK: Leading research peptide manufacturer, Cambridge Research Biochemicals (CRB) announced today that it will be expanding its business into Asia through the signing of an exclusive deal with <a href="http://biobridge.co.jp/e/index.html">BioBridge</a>. BioBridge will be responsible for the sales and marketing of CRB’s custom services in Japan.]]></description>
		<pubDate>Tue, 27 Mar 2012 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[Cambridge Research Biochemicals signs agreement with Life Technologies to offer custom dye labelled antibodies]]></title>
		<link>http://www.crbdiscovery.com/news/21_11-Jan-12.php</link>
		<description><![CDATA[Cambridge Research Biochemicals, the specialist peptide and custom antibody manufacturer based in the North East of England, has announced a significant expansion to its dye labelling offering. The company has signed an extension to its Supply &amp; Licence Agreement with Life Technologies &ndash; Molecular Probes. The deal extends CRB&rsquo;s licence to offer dye-labelled primary antibodies as well as peptides.]]></description>
		<pubDate>Wed, 11 Jan 2012 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[Quotient Bioresearch signs strategic alliance with Cambridge Research Biochemicals]]></title>
		<link>http://www.crbdiscovery.com/news/20_30-Jun-11.php</link>
		<description><![CDATA[Quotient Bioresearch, a leading provider of early stage and specialist drug development services to pharmaceutical, biotechnology and medical device clients worldwide, has signed a strategic partnership agreement with Cambridge Research Biochemicals to provide a joint consultancy solution for tritium peptide labelling, offering significant cost and time savings to customers.]]></description>
		<pubDate>Thu, 30 Jun 2011 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[Cambridge Research Biochemicals expands peptide manufacturing capacity]]></title>
		<link>http://www.crbdiscovery.com/news/19_08-Apr-11.php</link>
		<description><![CDATA[UK company is first in Europe to acquire powerful new synthesiser]]></description>
		<pubDate>Fri, 08 Apr 2011 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[CRB and Durham University launch medical research project]]></title>
		<link>http://www.crbdiscovery.com/news/18_22-Mar-11.php</link>
		<description><![CDATA[North-East specialist peptide manufacturer Cambridge Research Biochemicals (CRB) has teamed up with Durham University to carry out important health research.]]></description>
		<pubDate>Tue, 22 Mar 2011 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[Double first for Cambridge Research Biochemicals]]></title>
		<link>http://www.crbdiscovery.com/news/17_06-Dec-10.php</link>
		<description><![CDATA[Industry award recognises outstanding growth, grant spurs further capital investment]]></description>
		<pubDate>Mon, 06 Dec 2010 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[Cambridge Research Biochemicals appointed as peptide and antibody supplier by RCUK Shared Services Centre Limited]]></title>
		<link>http://www.crbdiscovery.com/news/16_16-Jun-10.php</link>
		<description><![CDATA[New contract a "significant win" for UK manufacturer]]></description>
		<pubDate>Wed, 16 Jun 2010 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[CRB signs distribution deal for new dyes]]></title>
		<link>http://www.crbdiscovery.com/news/15_12-Nov-09.php</link>
		<description><![CDATA[Cambridge Research Biochemicals signs distribution deal for new dyes
Research support company Cambridge Research Biochemicals Limited (&lsquo;CRB&rsquo;; Billingham, Teesside, UK) has signed a distribution agreement with Italian company Cyanagen to market Cyanagen&rsquo;s groundbreaking range of <a href="../products/fluorescent-dyes/">fluorescent labelling dyes</a> exclusively in the UK and Ireland and non-exclusively internationally.]]></description>
		<pubDate>Thu, 12 Nov 2009 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[CRB to be part of groundbreaking European initiative]]></title>
		<link>http://www.crbdiscovery.com/news/14_13-Apr-09.php</link>
		<description><![CDATA[Research support company Cambridge Research Biochemicals (CRB) Limited has secured a key role in a European initiative to bring together experts in scientific research from across Europe.]]></description>
		<pubDate>Mon, 13 Apr 2009 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[Grant sparks chemical reaction at North East firm]]></title>
		<link>http://www.crbdiscovery.com/news/13_24-Mar-09.php</link>
		<description><![CDATA[Grant investment from One North East is providing the catalyst for expansion at a regional chemical firm.]]></description>
		<pubDate>Tue, 24 Mar 2009 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[Not Just Dead Bodies!]]></title>
		<link>http://www.crbdiscovery.com/news/12_NA-Oct-08.php</link>
		<description><![CDATA[Our screens are inundated with forensic pathologists Silent Witness, CSI, Waking the Dead but is this what pathology is all about?  <strong>Pathology on the Screen &ndash; fact or fiction?</strong> at the Arts Picturehouse on Tuesday 4th November will show the concluding episode of the current BBC series of Silent Witness and give the audience the chance to ask real-life pathologists about their work.]]></description>
		<pubDate>Wed, 01 Oct 2008 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[CRB to provide monoclonal antibody production]]></title>
		<link>http://www.crbdiscovery.com/news/11_NA-Sep-08.php</link>
		<description><![CDATA[Cambridge Research Biochemicals (CRB), a specialist in the custom production of polyclonal antibodies, is now expanding its antibody offering to include monoclonal antibody production via two new agreements with Babraham Bioscience Technologies (BBT) and Epitomics Inc.]]></description>
		<pubDate>Mon, 01 Sep 2008 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[CRB becomes Panagene distributor]]></title>
		<link>http://www.crbdiscovery.com/news/10_NA-Nov-07.php</link>
		<description><![CDATA[Cambridge Research Biochemicals (CRB) has signed an agreement with Panagene to become the UK distributor for high purity peptide nucleic acids (PNA) oligomers. PNAs have many applications in bio-procedures, diagnostics, and anti-gene therapies.]]></description>
		<pubDate>Thu, 01 Nov 2007 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[Cambridge Research Biochemicals expands dye offering]]></title>
		<link>http://www.crbdiscovery.com/news/09_NA-Sep-07.php</link>
		<description><![CDATA[Cambridge Research Biochemicals (Billingham, UK), the specialist peptide and custom antibody manufacturer, has announced a new partnership with the Molecular Probes business of <a href="http://probes.invitrogen.com/">Invitrogen Corporation</a>, a provider of essential life science technologies for disease research and drug discovery (Carlsbad, CA, USA). The agreement grants Cambridge Research Biochemicals (CRB) a non-exclusive license to the full range of Molecular Probes dyes, including Alexa Fluor&reg;, BODIPY&reg;, Oregon Green&reg; and Texas Red&reg;fluorophores, enabling CRB to offer one of the most comprehensive custom labelling services available for fluorescent peptides. The license specifically allows CRB to attach all the proprietary dyes such as Alexa Fluor&reg; dyes to its own custom-made peptides to meet customer requirements.]]></description>
		<pubDate>Sat, 01 Sep 2007 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[A new partnership between Newcastle University and Teesside Specialty Biochemical Company]]></title>
		<link>http://www.crbdiscovery.com/news/08_NA-Jul-07.php</link>
		<description><![CDATA[One NorthEast has funded a Collaborative Innovative Partnership (CIP) between Cambridge Research Biochemicals, a leading specialist biochemicals manufacturer based in Billingham, and the Institute of Cellular Medicine at Newcastle University.]]></description>
		<pubDate>Sun, 01 Jul 2007 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[Across the Spectrum Fluorescent Labelling]]></title>
		<link>http://www.crbdiscovery.com/news/07_NA-May-07.php</link>
		<description><![CDATA[CRB specialise in the synthesis of fluorescently labelled peptides and antibodies. We can fluorescently label material at your wavelength of choice using your preferred dye.]]></description>
		<pubDate>Tue, 01 May 2007 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[New on-line dye selector and project tracker]]></title>
		<link>http://www.crbdiscovery.com/news/06_03-Feb-07.php</link>
		<description><![CDATA[Cambridge Research Biochemicals, the business specialising in the chemical synthesis of peptides and the custom production of polyclonal antibodies, is providing an increased range of services via its new look website.]]></description>
		<pubDate>Sat, 03 Feb 2007 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[CyDye&trade; - labelled peptides direct from CRB]]></title>
		<link>http://www.crbdiscovery.com/news/05_NA-Jun-04.php</link>
		<description><![CDATA[CRB has now strengthened its relationship with GE Healthcare (formerly Amersham Biosciences) and is now the world exclusive licensed supplier of custom Cydye&trade; labelled peptides. CRB is synonymous with providing high quality peptides and complex labelling syntheses, and therefore is the natural partner of choice for GE Healthcare's Fluorescent Screening Reagents business. CyDye&trade; fluorophores are a popular choice for labelling in a variety of fluorescence based applications including drug screening and assay development.]]></description>
		<pubDate>Tue, 01 Jun 2004 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[Antibody project tracking ONLINE!]]></title>
		<link>http://www.crbdiscovery.com/news/04_NA-Apr-03.php</link>
		<description><![CDATA[CRB has been supporting major pharmaceutical discovery programmes by providing bespoke antibodies for over 20 years. Our high quality, targeted antibodies are achieved through our persistent striving for optimal titres and concern for quality at every step. As part of our project management service, customers can now access real-time information at every stage of antibody production. Antibody project tracking is now conveniently available via the customer area of our website. This new service allows customers to check project progress and view past antibody projects online. Access is via a secure password system to protect confidentiality.]]></description>
		<pubDate>Tue, 01 Apr 2003 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[CyDye&trade; - labelled peptides deal with Amersham Biosciences]]></title>
		<link>http://www.crbdiscovery.com/news/03_NA-Nov-01.php</link>
		<description><![CDATA[We are pleased to announce that Cambridge Research Biochemicals Ltd have entered into an exclusive agreement with Amersham Biosciences to synthesise and label peptides with the CyDye&trade; fluorophores suitable for use in steady state fluorescence, fluorescent polarisation and FRET applications. For more details on the use of CyDye&trade; fluors in Drug Screening and to request a quotation then please contact your local Amersham Biosciences office or visit their web site at <a href="http://www1.amershambiosciences.com/aptrix/upp00919.nsf/Content/drugscr_applic_cydye">www.amershambiosciences.com</a>]]></description>
		<pubDate>Thu, 01 Nov 2001 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[New standard ISO9001:2000 Registration for CRB]]></title>
		<link>http://www.crbdiscovery.com/news/02_NA-Oct-01.php</link>
		<description><![CDATA[Cambridge Research Biochemicals are pleased to announce their registration to the new ISO9001:2000 quality standard. National Quality Assurance Limited (NQA) certified the quality management system of CRB in October, 2001, only 7 months after CRB's relocation to new expanded premises. CRB is fully committed to continuous business improvement to maintain and delight it's loyal and long-serving customers.]]></description>
		<pubDate>Mon, 01 Oct 2001 00:00:01 GMT</pubDate>
	</item>
	<item>
		<title><![CDATA[Cambridge Research Biochemicals relocate]]></title>
		<link>http://www.crbdiscovery.com/news/01_NA-Apr-01.php</link>
		<description><![CDATA[Cambridge Research Biochemicals are pleased to announce a relocation of operations to new premises. From 2nd April, 2001, CRB moved to it's own dedicated and custom-designed facilities at:]]></description>
		<pubDate>Sun, 01 Apr 2001 00:00:01 GMT</pubDate>
	</item>
</channel>
</rss>

